Abstract:Aims: Diabetic cardiomyopathy (DC) is one of serious complications of diabetic patients. This study investigated the biological function of activating transcription factor 4 (ATF4) in DC. Methods and results: Streptozotocin-treated mice and high glucose (HG)-exposed HL-1 cells were used as the in vivo and in vitro models of DC. Myocardial infarction (MI) was induced by left coronary artery ligation in mice. Cardiac functional parameters were detected by echocardiography. Target molecule expression was determined by real time quantitative PCR and western blotting. Cardiac fibrosis was observed by haematoxylin and eosin and Masson's staining. Cardiac apoptosis was evaluated by terminal deoxynucleotidyl transferase dUTP nick end labelling. Activities of superoxide dismutase, glutathione peroxidase, and levels of malonic dialdehyde and reactive oxygen species were used to assess oxidative stress damage. Molecular mechanisms were evaluated by chromatin immunoprecipitation, dual luciferase assay, and co-immunoprecipitation. ATF4 was up-regulated in the DC and MI mice (P < 0.01). Down-regulation of ATF4 improved cardiac function as evidenced by changes in cardiac functional parameters (P < 0.01), inhibited myocardial collagen I (P < 0.001) and collagen III (P < 0.001) expression, apoptosis (P < 0.001), and oxidative stress (P < 0.001) in diabetic mice. Collagen I (P < 0.01) and collagen III (P < 0.01) expression was increased in MI mice, which was reversed by ATF4 silencing (P < 0.05). ATF4 depletion enhanced viability (P < 0.01), repressed apoptosis (P < 0.001), oxidative damage (P < 0.001), and collagen I (P < 0.001), and collagen III (P < 0.001) expression of HG-stimulated HL-1 cells. ATF4 transcriptionally activated Smad ubiquitin regulatory factor 2 (Smurf2, P < 0.001) to promote ubiquitination and degradation of homeodomain interacting protein kinase-2 (P < 0.001) and subsequently caused inactivation of nuclear factor erythroid 2-related factor 2/heme oxygenase 1 pathway (P < 0.001). The inhibitory effects of ATF4 silencing on HG-induced apoptosis (P < 0.01), oxidative injury (P < 0.01), collagen I (P < 0.001), and collagen III (P < 0.001) expression were reversed by Smurf2 overexpression. Conclusions: ATF4 facilitates diabetic cardiac fibrosis and oxidative stress by promoting Smurf2-mediated ubiquitination and degradation of homeodomain interacting protein kinase-2 and then inactivation of nuclear factor erythroid 2-related factor 2/heme oxygenase 1 pathway, suggesting ATF4 as a treatment target for DC.

Effects of Activating Transcription Factor 4 Deficiency on Carbohydrate and Lipid Metabolism in Mammals

ATF4 Regulates Lipid Metabolism and Thermogenesis

Activating transcription factor 4: a regulator of stress response in human cancers

Effects of ATF4 on PGC1α expression in brown adipose tissue and metabolic responses to cold stress.

Activating Transcription Factor 3, Glucolipid Metabolism, and Metabolic Diseases

ATF4 Protein Deficiency Protects Against High Fructose-induced Hypertriglyceridemia in Mice*

Activating transcription factor 4 regulates adipocyte differentiation via altering the coordinate expression of CCATT/enhancer binding protein β and peroxisome proliferator-activated receptor γ.

ATF4 in cellular stress, ferroptosis, and cancer

ATF4 Regulates CD4+ T Cell Immune Responses Through Metabolic Reprogramming

Atf4 protects islet β-cell identity and function under acute glucose-induced stress but promotes β-cell failure in the presence of free fatty acid

ATF4 Deficiency Protects Hepatocytes from Oxidative Stress Via Inhibiting CYP2E1 Expression

Atf4 protects islet beta-cell identity and function under acute glucose-induced stress but promotes beta-cell failure in the presence of free fatty acid

Activating Transcription Factor 4 Regulates Angiogenesis under Lipid Overload Via Methionine Adenosyltransferase 2a‐mediated Endothelial Epigenetic Alteration

ATF4/ATG5 Signaling in Hypothalamic Proopiomelanocortin Neurons Regulates Fat Mass via Affecting Energy Expenditure

ATF4 Deficiency Protects Mice from High-Carbohydrate-diet-induced Liver Steatosis

Activating transcription factor 4 drives the progression of diabetic cardiac fibrosis

Cooperation of ATF4 and CTCF Promotes Adipogenesis Through Transcriptional Regulation.

Central Activating Transcription Factor 4 (Atf4) Regulates Hepatic Insulin Resistance In Mice Via S6k1 Signaling And The Vagus Nerve

Deletion of ATF4 in AgRP Neurons Promotes Fat Loss Mainly Via Increasing Energy Expenditure

Activating transcription factor 5 regulates lipid metabolism in adipocytes

An ATF4-ATG5 Signaling in Hypothalamic POMC Neurons Regulates Obesity.